央视网消息：新修订的《中华人民共和国药品管理法实施条例》27日发布，将于5月15日正式施行。作为《药品管理法》配套行政法规， 这是条例实施23年来首次全面修订。新规出台后将如何更好满足群众用药需求呢？ 新修订《药品管理法实施条例》公布 见病用药品给予不超过7年的市场独占期。 国家药监局相关负责人介绍，现行《药品管理法实施条例》是2002年公布、施行，曾有3次对个别条款进行修改，这次修订是《条例》施 行23年来的首次全面修订，修改的条款达到90%以上。 国家药监局政策法规司司长 张琪：现行《条例》以对药品生产经营企业的管理为中心，修订后转变为以药品上市许可持有人为中心，落 实持有人主体责任，强化药品全生命周期全过程严格监管。 四条加快上市通道缩短患者等药盼药时间 新修订《条例》正式将突破性治疗药物、附条件批准、优先审评审批和特别审批这四条加快上市通道，在行政法规中予以明确。 加强药品知识产权保护 兼顾药品创新与惠民 新修订《条例》拓展了药品试验数据保护制度，首次引入了药品市场独占期制度，加强药品知识产权保护。充分考虑保护特殊群体的用药 权益，将药品市场独占期制度等扩展到罕见病用药品、儿童用药品。对符合条件的儿童 ...

Group 1: Market Regulation Achievements - The National Market Regulation Administration has improved the regulatory system for enterprise-related fees, continuously reducing operational costs for businesses, resulting in a net increase of 19.99 million enterprises and 33.946 million individual businesses during the "14th Five-Year Plan" period [1][2] - The introduction of the "Fair Competition Review Regulations" has established rigid institutional constraints against issues like malicious competition in investment promotion and administrative monopolies, with 4,218 obstructive policies abolished and 239 administrative monopoly cases investigated [1][2] Group 2: Consumer Protection and Efficiency - A total of 89.028 million complaints were handled by market regulation departments, recovering economic losses of 21.71 billion yuan for consumers, while consumer associations processed 5.749 million complaints, recovering 5.78 billion yuan [2] - The time to open a restaurant has been reduced from 37 days to 15 days, and the number of documents required for business information changes has been streamlined from 23 to 6 [2] Group 3: Platform Economy Regulation - The market regulation authority is addressing potential risks in the platform economy, such as algorithm abuse and disorderly competition, by balancing innovation encouragement and regulatory development [3][4] - Significant actions have been taken against market irregularities, including the removal of 4.541 million illegal product listings and the investigation of 105,000 internet-related cases [4] Group 4: Pharmaceutical Industry Growth - The pharmaceutical industry in China ranks second globally, with 204 innovative drugs and 265 innovative medical devices approved during the "14th Five-Year Plan," and 50 innovative drugs approved in the first seven months of this year [5][6] - The National Medical Products Administration has implemented dynamic supervision covering the entire drug lifecycle, focusing on key areas such as online sales and clinical trial management, while conducting over 200,000 drug inspections annually [6]